Roivant Sciences received rating updates and price targets from Bank of America, Citigroup, and Leerink Partners.

The entities involved

• Roivant Sciences (United States) →

  company in New York, United States

  • Eric Venker has been named the CEO of Roivant Sciences Ltd.Sun 21:21
  • Roivant Social Ventures made a six-figure legacy donation to No Patient Left Behind.Thu 15:19
• Bank of America →

  American multinational banking and financial services corporation

  • Bank of America dropped its price objective on November 4, 2026.14:49
  • Market competition driven by AI and rising Treasury yields is causing market volatility involving AbbVie, Bank of America, Adobe, and Accenture.12:59
• Citigroup →

  American investment bank and financial services corporation

  • Citigroup lifted its price objective on Newmont Corporation stock.14:25
  • Multiple financial firms issued rating and price target updates on November 4, 2026.14:11

Related events

• Bank of America updated its price objective and rating, while Citigroup reissued a neutral rating on Biogen shares.12:15
• Citigroup reissued a buy rating on Bankinter.Oct 20
• Bank of America set a buy rating and price target for Penguin Solutions on October 23, 2026.Oct 24
• Citigroup reiterated a neutral rating on Norfolk Southern stock, while JPMorgan Chase & Co. issued a price target report.Oct 23
• Bank of America influenced stock rating and target price for Commercial Metals Company, with MarketBeat aggregating the data.Sep 9